CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Isn't it true that people who have conversations with themselves under multiple different identities are exhibiting texbook symptoms of schizophrenic alcoholic dementia?

Perhaps someone with laser-guided insights could comment on this. And perhaps share any insights he/she may also have on how long it takes for schizophrenic alcoholic dementia to progress to end-stage liver disease. Is it also true that progression occurs more rapidly in patients who are of Northern European descent?

And isn't it true that Venturis Therpeutics/CVBT recently filed a patent on treating schizophrenic alcoholic dementia with its drug?

I'm sure we will hear the details of this in the 2021 shareholders meeting which will be held in May 2021 as required by the company's bylaws. Oh wait...there is no shareholders meeting being held in May 2021, in violation of the company's bylaws AND Calvin Wallen's written promises to the shareholders, FOR THE SECOND YEAR IN A ROW.

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157492465